Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant - Related Studies

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

This study has been completed.

Study NCT00118742. Last updated on October 15, 2008. Information provided by Hoffmann-La Roche

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Liver Transplantation

2	Interventions listed in this trial
		mycophenolate mofetil [CellCept]
		Tacrolimus
		Cyclosporine
		Sirolimus

3	Additional drug interventions recognized in this trial
		Cyclosporins
		Mycophenolate mofetil
		Mycophenolic Acid

4	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antifungal Agents
		Antineoplastic Agents
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

5	Sponsors listed in this trial
		Hoffmann-La Roche